The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples